Corbus Pharmaceuticals Holdings, Inc. Deferred Revenue
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Deferred Revenue of $270.53 thousand as of 2020-06-30, per its 10-Q/A filed 2020-08-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2020-08-31
- 2020-06-30: Deferred Revenue, Current $270.53K.
- 2018-12-31: Deferred Revenue, Current $1.46M.
- 2018-09-30: Deferred Revenue, Current $3.39M.
- 2018-06-30: Deferred Revenue, Current $4.48M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2020-06-30 | $270.53K 10-Q/A · filed 2020-08-31 |
| 2018-12-31 | $1.46M 10-K · filed 2020-03-16 |
| 2018-09-30 | $3.39M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.48M 10-Q · filed 2018-08-08 |
| 2017-06-30 | $296.31K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $646.50K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.94M 10-K · filed 2018-03-12 |
| 2016-09-30 | $1.32M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.06M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $1.46M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.59M 10-K · filed 2017-03-08 |
| 2015-09-30 | $681.82K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $681.62K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |